{"id":815394,"date":"2025-02-20T07:03:43","date_gmt":"2025-02-20T12:03:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/"},"modified":"2025-02-20T07:03:43","modified_gmt":"2025-02-20T12:03:43","slug":"skye-bioscience-to-present-at-td-cowen-health-care-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/","title":{"rendered":"Skye Bioscience to Present at TD Cowen Health Care Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN DIEGO, Calif., Feb.  20, 2025  (GLOBE NEWSWIRE) &#8212; Skye Bioscience, Inc. (Nasdaq: SKYE) (\u201cSkye\u201d), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that Punit Dhillon, Chief Executive Officer, will present a corporate overview and be available for 1&#215;1 meetings at the TD Cowen 45th Annual Health Care Conference.<\/p>\n<ul type=\"disc\">\n<li>Presentation Date: Wednesday, March 5, 2025<\/li>\n<li>Time: 11:10 AM \u2013 11:40 AM ET<\/li>\n<li>Location: Boston, MA<\/li>\n<\/ul>\n<p>A live and archived webcast will be accessible on Skye\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=glpt-dpVlS2q4Cw0ljHoJ0ndQlVeshZOZHoioqVIQJJWwPWc_KgVKItpVPvQc8KABnbbJtJ-S_GK-cZNrQ9XTKHEk3wdvbzvykUc1uzv-x6XcFjadvzKQWY4uc1D5aCQwMDUMGW2175At1SMEhk3mQ==\" rel=\"nofollow\" target=\"_blank\"><u>website<\/u><\/a>.<\/p>\n<p>\n        <strong>About Skye Bioscience <\/strong>\n      <\/p>\n<p align=\"justify\">Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye&#8217;s strategy leverages biologic targets with substantial human proof of mechanism for the development of first-in-class therapeutics with clinical and commercial differentiation. Skye is conducting a Phase 2 clinical trial (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5qdIhbWbJRcrhAX0r3IbTtvAwCei8KZ6An0ojD_JHHnqPhPIotSejn8o7MyYi_6u3ltWytVafYq_GZoIbjJSEEqTq2wUL_gyjt2VGdvsDfzJ61UicnL2vFL7sGRdk2b3nilQa4PIoI9c-rbAOlkomQ==\" rel=\"nofollow\" target=\"_blank\"><u>ClinicalTrials.gov: NCT06577090<\/u><\/a>) in obesity for nimacimab, a negative allosteric modulating antibody that peripherally inhibits CB1. This study is also assessing the combination of nimacimab and a GLP-1R agonist (Wegovy\u00ae). For more information, please visit: <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RDEuXW29xK2_eE5Ih7yLUMGGJ2Gra7i71sBuABictXiiu1WH3jr-IBkChP086OF2zqEM_Zozw1LGg4eP8wzktwAEcnFwP08w_mQctz4jAhE=\" rel=\"nofollow\" target=\"_blank\">www.skyebioscience.com<\/a><\/u>. Connect with us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kfFvFT_v7tbeIn-F06d6X493x3NSrGviEoEvc9hFE2KYvPZmmPfb6B6wyJvBlbR1JxWVNlCuea577f1snRL0Ag==\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7PwuuFy5uj7Pr0gY6HO22aOwjFR6pKZVLGVz4aEhCj5xrmaCXM08HhdvENLReGjyk_65Kwkj6edfn2-bLq5zZZsmrFt6TTXaWAzRAX1oggk=\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>.<\/p>\n<p>\n        <strong>CONTACTS<\/strong>\n      <\/p>\n<p>Investor Relations<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SgiVmErVEdFhqXfC6GrYZdmAiE171vmj44oJPjFpMSfRcubQQ24G8JkyAUms50ezR7iFT2jN7wITZCeNhQHTtHUBYhykQHA3IRCvm9iV2mQ=\" rel=\"nofollow\" target=\"_blank\">ir@skyebioscience.com<\/a><\/u><br \/>(858) 410-0266<\/p>\n<p>LifeSci Advisors, Mike Moyer<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tuLxbdd6fMnrB7msIPA4jdKDYr9VRl1Mjsye7EviHJK0vPN40MkAfMOj04ALZFoDd-h60uGpcNs87oeajUKMWmUw5F2PePxlGERAGwxP4FSGd29RTldpk0FCDODHpVjm\" rel=\"nofollow\" target=\"_blank\">mmoyer@lifesciadvisors.com<\/a><\/u><br \/>(617) 308-4306<\/p>\n<p>Media Inquiries<br \/>LifeSci Communications, Michael Fitzhugh<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OyCvNBHI2vSIGj94ZDznRvW3gqotqTYhKoMIJyiAYzVjDliFWv3T6zC9A0JEh29jbeQSt_mu0KRAreATKI3rQNTec1FsrFSyTubrmonEz9ohkzbKzlzeJuUFGNNSPC8s\" rel=\"nofollow\" target=\"_blank\">mfitzhugh@lifescicomms.com<\/a><\/u><br \/>(628) 234-3889<\/p>\n<p>\n        <strong>FORWARD LOOKING STATEMENTS<\/strong>\n      <\/p>\n<p align=\"justify\">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, forward-looking statements can be identified by terminology including \u201canticipated,\u201d \u201cplans,\u201d \u201cgoal,\u201d \u201cfocus,\u201d \u201caims,\u201d \u201cintends,\u201d \u201cbelieves,\u201d \u201ccan,\u201d \u201ccould,\u201d \u201cchallenge,\u201d \u201cpredictable,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201cmay\u201d or the negative of these terms or other comparable terminology. Such statements and other statements in this press release that are not descriptions of historical facts are forward-looking statements that are based on management\u2019s current expectations and assumptions and are subject to risks and uncertainties. If such risks or uncertainties materialize or such assumptions prove incorrect, our business, operating results, financial condition, and stock price could be materially negatively affected. We operate in a rapidly changing environment, and new risks emerge from time to time. As a result, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements the Company may make. Risks and uncertainties that may cause actual results to differ materially include, among others, our capital resources, uncertainty regarding the results of future testing and development efforts and other risks that are described in the Company\u2019s periodic filings with the Securities and Exchange Commission, including in the \u201cRisk Factors\u201d section of Skye\u2019s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Except as expressly required by law, Skye disclaims any intent or obligation to update these forward-looking statements.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTU0MSM2NzU5OTcxIzUwMDEyMDM5Nw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzYwNGM2MDMtN2Y3Mi00ZTM0LTg3ZGYtY2U1OWEwNTE5MDViLTUwMDEyMDM5Nw==\/tiny\/Skye-Bioscience-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) &#8212; Skye Bioscience, Inc. (Nasdaq: SKYE) (\u201cSkye\u201d), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that Punit Dhillon, Chief Executive Officer, will present a corporate overview and be available for 1&#215;1 meetings at the TD Cowen 45th Annual Health Care Conference. Presentation Date: Wednesday, March 5, 2025 Time: 11:10 AM \u2013 11:40 AM ET Location: Boston, MA A live and archived webcast will be accessible on Skye\u2019s website. About Skye Bioscience Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye&#8217;s strategy leverages biologic targets with substantial human &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Skye Bioscience to Present at TD Cowen Health Care Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815394","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Skye Bioscience to Present at TD Cowen Health Care Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Skye Bioscience to Present at TD Cowen Health Care Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) &#8212; Skye Bioscience, Inc. (Nasdaq: SKYE) (\u201cSkye\u201d), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that Punit Dhillon, Chief Executive Officer, will present a corporate overview and be available for 1&#215;1 meetings at the TD Cowen 45th Annual Health Care Conference. Presentation Date: Wednesday, March 5, 2025 Time: 11:10 AM \u2013 11:40 AM ET Location: Boston, MA A live and archived webcast will be accessible on Skye\u2019s website. About Skye Bioscience Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye&#8217;s strategy leverages biologic targets with substantial human &hellip; Continue reading &quot;Skye Bioscience to Present at TD Cowen Health Care Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T12:03:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTU0MSM2NzU5OTcxIzUwMDEyMDM5Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-td-cowen-health-care-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-td-cowen-health-care-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Skye Bioscience to Present at TD Cowen Health Care Conference\",\"datePublished\":\"2025-02-20T12:03:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-td-cowen-health-care-conference\\\/\"},\"wordCount\":498,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-td-cowen-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTU0MSM2NzU5OTcxIzUwMDEyMDM5Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-td-cowen-health-care-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-td-cowen-health-care-conference\\\/\",\"name\":\"Skye Bioscience to Present at TD Cowen Health Care Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-td-cowen-health-care-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-td-cowen-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTU0MSM2NzU5OTcxIzUwMDEyMDM5Nw==\",\"datePublished\":\"2025-02-20T12:03:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-td-cowen-health-care-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-td-cowen-health-care-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-td-cowen-health-care-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTU0MSM2NzU5OTcxIzUwMDEyMDM5Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTU0MSM2NzU5OTcxIzUwMDEyMDM5Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-td-cowen-health-care-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Skye Bioscience to Present at TD Cowen Health Care Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Skye Bioscience to Present at TD Cowen Health Care Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/","og_locale":"en_US","og_type":"article","og_title":"Skye Bioscience to Present at TD Cowen Health Care Conference - Market Newsdesk","og_description":"SAN DIEGO, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) &#8212; Skye Bioscience, Inc. (Nasdaq: SKYE) (\u201cSkye\u201d), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that Punit Dhillon, Chief Executive Officer, will present a corporate overview and be available for 1&#215;1 meetings at the TD Cowen 45th Annual Health Care Conference. Presentation Date: Wednesday, March 5, 2025 Time: 11:10 AM \u2013 11:40 AM ET Location: Boston, MA A live and archived webcast will be accessible on Skye\u2019s website. About Skye Bioscience Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye&#8217;s strategy leverages biologic targets with substantial human &hellip; Continue reading \"Skye Bioscience to Present at TD Cowen Health Care Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-20T12:03:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTU0MSM2NzU5OTcxIzUwMDEyMDM5Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Skye Bioscience to Present at TD Cowen Health Care Conference","datePublished":"2025-02-20T12:03:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/"},"wordCount":498,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTU0MSM2NzU5OTcxIzUwMDEyMDM5Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/","name":"Skye Bioscience to Present at TD Cowen Health Care Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTU0MSM2NzU5OTcxIzUwMDEyMDM5Nw==","datePublished":"2025-02-20T12:03:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTU0MSM2NzU5OTcxIzUwMDEyMDM5Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTU0MSM2NzU5OTcxIzUwMDEyMDM5Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-td-cowen-health-care-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Skye Bioscience to Present at TD Cowen Health Care Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815394"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815394\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}